鳥居薬品の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2018/03/20 | 2,706 | 2,719 | 2,696 | 2,714 | -15 | -0.5% | 19,600 |
2018/03/19 | 2,742 | 2,743 | 2,712 | 2,729 | -13 | -0.5% | 15,900 |
2018/03/16 | 2,773 | 2,778 | 2,710 | 2,742 | -23 | -0.8% | 30,000 |
2018/03/15 | 2,774 | 2,784 | 2,748 | 2,765 | -31 | -1.1% | 14,100 |
2018/03/14 | 2,806 | 2,816 | 2,775 | 2,796 | -21 | -0.7% | 13,400 |
2018/03/13 | 2,779 | 2,820 | 2,779 | 2,817 | +10 | +0.4% | 28,400 |
2018/03/12 | 2,797 | 2,810 | 2,775 | 2,807 | +32 | +1.2% | 13,400 |
2018/03/09 | 2,813 | 2,843 | 2,760 | 2,775 | -3 | -0.1% | 27,200 |
2018/03/08 | 2,854 | 2,854 | 2,765 | 2,778 | -51 | -1.8% | 27,400 |
2018/03/07 | 2,794 | 2,875 | 2,773 | 2,829 | +35 | +1.3% | 27,500 |
2018/03/06 | 2,816 | 2,836 | 2,780 | 2,794 | -1 | ±0% | 24,800 |
2018/03/05 | 2,778 | 2,822 | 2,778 | 2,795 | +8 | +0.3% | 25,400 |
2018/03/02 | 2,862 | 2,874 | 2,758 | 2,787 | -75 | -2.6% | 43,900 |
2018/03/01 | 2,931 | 2,933 | 2,840 | 2,862 | -81 | -2.8% | 49,900 |
2018/02/28 | 2,953 | 2,972 | 2,938 | 2,943 | -26 | -0.9% | 32,300 |
2018/02/27 | 2,979 | 2,979 | 2,912 | 2,969 | -10 | -0.3% | 26,200 |
2018/02/26 | 2,923 | 2,992 | 2,917 | 2,979 | +56 | +1.9% | 39,000 |
2018/02/23 | 2,922 | 2,935 | 2,868 | 2,923 | +68 | +2.4% | 45,200 |
2018/02/22 | 2,860 | 2,869 | 2,801 | 2,855 | +40 | +1.4% | 45,300 |
2018/02/21 | 2,751 | 2,834 | 2,736 | 2,815 | +64 | +2.3% | 48,700 |
2018/02/20 | 2,752 | 2,784 | 2,744 | 2,751 | +15 | +0.5% | 34,200 |
2018/02/19 | 2,718 | 2,737 | 2,694 | 2,736 | -24 | -0.9% | 68,200 |
2018/02/16 | 2,750 | 2,799 | 2,745 | 2,760 | -3 | -0.1% | 42,200 |
2018/02/15 | 2,739 | 2,822 | 2,733 | 2,763 | +24 | +0.9% | 30,100 |
2018/02/14 | 2,770 | 2,785 | 2,720 | 2,739 | -31 | -1.1% | 28,600 |
2018/02/13 | 2,800 | 2,859 | 2,762 | 2,770 | +14 | +0.5% | 50,700 |
2018/02/09 | 2,683 | 2,810 | 2,683 | 2,756 | -9 | -0.3% | 87,400 |
2018/02/08 | 2,702 | 2,791 | 2,702 | 2,765 | +84 | +3.1% | 82,800 |
2018/02/07 | 2,905 | 2,925 | 2,680 | 2,681 | -222 | -7.6% | 191,600 |
2018/02/06 | 2,990 | 3,010 | 2,820 | 2,903 | -147 | -4.8% | 116,900 |
2018/02/05 | 3,035 | 3,070 | 3,035 | 3,050 | -55 | -1.8% | 32,500 |
2018/02/02 | 3,130 | 3,130 | 3,100 | 3,105 | -10 | -0.3% | 19,000 |
2018/02/01 | 3,090 | 3,120 | 3,075 | 3,115 | +25 | +0.8% | 24,800 |
2018/01/31 | 3,095 | 3,130 | 3,080 | 3,090 | -25 | -0.8% | 31,000 |
2018/01/30 | 3,150 | 3,150 | 3,100 | 3,115 | -55 | -1.7% | 51,100 |
2018/01/29 | 3,205 | 3,215 | 3,155 | 3,170 | -35 | -1.1% | 33,400 |
2018/01/26 | 3,200 | 3,220 | 3,190 | 3,205 | ±0 | ±0% | 35,900 |
2018/01/25 | 3,200 | 3,235 | 3,185 | 3,205 | +20 | +0.6% | 67,000 |
2018/01/24 | 3,130 | 3,195 | 3,110 | 3,185 | +25 | +0.8% | 121,100 |
2018/01/23 | 3,295 | 3,305 | 3,125 | 3,160 | +140 | +4.6% | 391,500 |
2018/01/22 | 3,005 | 3,020 | 2,996 | 3,020 | +10 | +0.3% | 16,100 |
2018/01/19 | 3,045 | 3,050 | 3,000 | 3,010 | -45 | -1.5% | 14,000 |
2018/01/18 | 3,085 | 3,085 | 3,050 | 3,055 | -30 | -1% | 22,300 |
2018/01/17 | 3,090 | 3,090 | 3,065 | 3,085 | -5 | -0.2% | 16,200 |
2018/01/16 | 3,115 | 3,115 | 3,085 | 3,090 | -25 | -0.8% | 12,200 |
2018/01/15 | 3,075 | 3,115 | 3,075 | 3,115 | +60 | +2% | 31,900 |
2018/01/12 | 3,050 | 3,070 | 3,040 | 3,055 | -10 | -0.3% | 20,200 |
2018/01/11 | 3,065 | 3,065 | 3,040 | 3,065 | -10 | -0.3% | 18,300 |
2018/01/10 | 3,055 | 3,080 | 3,030 | 3,075 | +10 | +0.3% | 20,700 |
2018/01/09 | 3,100 | 3,105 | 3,055 | 3,065 | -45 | -1.4% | 23,800 |
1751~
1800
件表示中 / 3705件
類似銘柄と比較する
現在ご覧いただいている「鳥居薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
鳥居薬 | 633,000円 | +7.1% | -35.0% | 0.00% | 52.34倍 | 1.46倍 |
|
JT傘下。柱の抗HIV薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
ペプチド | 167,300円 | +5.0% | +1.5% | 0.00% | 14.31倍 | 3.81倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
キッセイ薬 | 385,500円 | +3.6% | +6.1% | 3.11% | 12.99倍 | 0.76倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
科研薬 | 373,800円 | -6.4% | -71.8% | 5.08% | 41.63倍 | 0.93倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の2本柱。後発品も展開 |
東和薬品 | 299,500円 | +7.9% | -3.3% | 2.67% | 8.33倍 | 0.86倍 |
|
後発医薬品メーカーで国内2強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
市場注目の銘柄
チャート関連のコラム